Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in Hospital Acquired Pneumonia
NCT03121690Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Dec 2017
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hospital-acquired pneumonia (HAP) comparing Prednisone with Placebo (2 arms). Primary endpoint: Percentage of Hospital mortality at 28 days. Status: unknown.
02
Drugs
prednisone
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT03121690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03121690.